- Home
- CHNR vs PRTG Comparison
CHNR vs PRTG Comparison
Compare CHNR & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- PRTG
- Stock Information
- Founded
- CHNR N/A
- PRTG 1973
- Country
- CHNR Hong Kong
- PRTG British Virgin Islands
- Employees
- CHNR N/A
- PRTG N/A
- Industry
- CHNR Precious Metals
- PRTG Oil & Gas Production
- Sector
- CHNR Basic Materials
- PRTG Energy
- Exchange
- CHNR Nasdaq
- PRTG Nasdaq
- Market Cap
- CHNR 6.4M
- PRTG 5.3M
- IPO Year
- CHNR 1995
- PRTG N/A
- Fundamental
- Price
- CHNR $0.66
- PRTG $4.09
- Analyst Decision
- CHNR
- PRTG Hold
- Analyst Count
- CHNR 0
- PRTG 1
- Target Price
- CHNR N/A
- PRTG N/A
- AVG Volume (30 Days)
- CHNR 27.1K
- PRTG 51.0K
- Earning Date
- CHNR 01-01-0001
- PRTG 11-26-2024
- Dividend Yield
- CHNR N/A
- PRTG N/A
- EPS Growth
- CHNR N/A
- PRTG N/A
- EPS
- CHNR N/A
- PRTG N/A
- Revenue
- CHNR N/A
- PRTG N/A
- Revenue This Year
- CHNR N/A
- PRTG N/A
- Revenue Next Year
- CHNR N/A
- PRTG N/A
- P/E Ratio
- CHNR N/A
- PRTG N/A
- Revenue Growth
- CHNR N/A
- PRTG N/A
- 52 Week Low
- CHNR $0.55
- PRTG $2.10
- 52 Week High
- CHNR $8.85
- PRTG $40.80
- Technical
- Relative Strength Index (RSI)
- CHNR 46.40
- PRTG 35.81
- Support Level
- CHNR $0.62
- PRTG $3.80
- Resistance Level
- CHNR $0.73
- PRTG $4.49
- Average True Range (ATR)
- CHNR 0.06
- PRTG 0.53
- MACD
- CHNR -0.00
- PRTG -0.15
- Stochastic Oscillator
- CHNR 49.94
- PRTG 12.12
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.